AppliedVR Secures $29 Million in Series A Funding to Make Virtual Reality the Standard of Care for Chronic Pain

24 Mar, 2021

AppliedVR Secures $29 Million in Series A Funding to Make Virtual Reality the Standard of Care for Chronic Pain
Photo by Mia Baker on Unsplash

– AppliedVR, a pioneer advancing the next generation of digital medicine, today announced $29m in series A funding, bringing its total funds raised to $35m.
– The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.
– AppliedVR provides virtual reality-based treatments aimed at comprehensively treating chronic pain. Combining well-established cognitive behavioral therapies with mindfulness exercises, the company’s EaseVRx solution recently became the first VR prescription therapeutic to receive Breakthrough Device Designation from the FDA for treatment-resistant fibromyalgia and chronic intractable lower back pain.

Enterprise Software Health Care North America Virtual Reality
Crunchbase icon

Content report

The following text will be sent to our editors: